SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 29 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80 | -29.8% | 100,000 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $114 | -24.0% | 100,000 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $150 | -99.9% | 100,000 | 0.0% | 0.01% | -14.3% |
| Q4 2022 | $149,000 | -3.9% | 100,000 | 0.0% | 0.01% | -22.2% |
| Q3 2022 | $155,000 | -31.7% | 100,000 | 0.0% | 0.01% | -43.8% |
| Q2 2022 | $227,000 | -1.7% | 100,000 | 0.0% | 0.02% | +60.0% |
| Q1 2022 | $231,000 | -60.2% | 100,000 | 0.0% | 0.01% | -52.4% |
| Q4 2021 | $580,000 | -44.9% | 100,000 | 0.0% | 0.02% | -38.2% |
| Q3 2021 | $1,052,000 | +7.8% | 100,000 | 0.0% | 0.03% | +41.7% |
| Q2 2021 | $976,000 | -32.8% | 100,000 | 0.0% | 0.02% | -25.0% |
| Q1 2021 | $1,453,000 | – | 100,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newtyn Management, LLC | 1,155,561 | $1,721,786 | 0.36% |
| Western Standard LLC | 46,117 | $68,714 | 0.06% |
| Deuterium Capital Management, LLC | 11,900 | $17,731 | 0.05% |
| Duquesne Family Office | 100,000 | $149,000 | 0.01% |
| Virtu Financial LLC | 26,060 | $39 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 112,900 | $168,221 | 0.00% |
| Ergoteles LLC | 34,340 | $51,167 | 0.00% |
| UBS Group AG | 1,097 | $1,635 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 31,076 | $46,303 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 11,570 | $17 | 0.00% |